Font Size: a A A
Keyword [CAG regimen]
Result: 1 - 20 | Page: 1 of 2
1. Mechanism Of CAG Regimen Eliminating T-cell Acute Lymphoblastic Leukemia Cells Of A3 Cell Line
2. A Study On The Therapy Of Previously Untreated Elderly Patients With Acute Myeloid Leukemia
3. Decitabine And Modified CAG Regimen Plus Haplotype Identical Donor Lymphocyte Infusion As Induction Chemotherapy For Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
4. Clinical Observation Of CAG Regimen On Patients With High Risk Myelodysplastic Syndrome
5. Study Of The Effect Of Decitabine And The Vivo Methylation Levels In The Patients Of Acute Myeloid Leukemia And Myelodysplastic Syndromes Who Treated With Decitabine
6. Efficacy And Safety Of Decitabine, CAG And Decitabine Combined With CAG Regimen In The Treatment Of Myelodysplastic Syndromes
7. Comparison Analysis Of Decitabine Combined With CAG Chemotherapy Regimens In Treating Elderly Acute Myeloid Leukemia
8. Basic And Clinical Research Of Decitabine Combined Modified CAG In The Treatment Of AML Patients
9. The Cliniical Efficacy Of The Elderly Patients Of Myelodysplastic Syndrome, Treated With The Decitabine Combined With CAG Regimen
10. The Clinical Efficacy And Safety Between Decitabine Combined With CAG Regimen And IA Regimen Inptreatment Of Newly Diagnosed Elderly Patients With Acute Myeloid Leukemia
11. The Analysis Of Clinical Efficacy Of Decitabine Combined With CAG Regimen In Treatment Of Elderly And Refractory/Relapsed Acute Myeloid Leukemia
12. Clinical Study Of Decitabine Combined With Half Dose CAG Regimen In The Treatment Of Elderly AML
13. Clinical Study Of Decitabine Combined With CAG Regimen In Acute Myeloid Leukemia
14. Clinical Efficacy Analysis Of Decitabine In Patients With Intermediate Or High-Risk Myelodysplastic Syndrome And Combined With CAG Regimen In Patients With Elderly And Refractory Or Relapsed Acute Myeloid Leukemia
15. Comparison Of Clinical Efficacy Between Low-dose Ma Regimen And Cag Regimen In The Elderly Patients With Acute Myeloid Leukemia(AML)
16. The Clinical Efficacy And Safety On Patients With AML And MDS-RAEB Treated By CAG Regimen
17. Clinical Observation Of Turmeric Powder Plus Or Minus CAG Regimen In The Treatment Of Recurrent And Refractory Acute Myeloid Leukemia With Blood Stasis Syndrome
18. The Clinical Study Of Decitabine Combined With Low-dose CAG Regimen In The Treatment Of Elderly Acute Myeloid Leukemia
19. Initiatory Efficacy Of CAG Regimen,Decitabine Alone And Decitabine Combined With Half-dose CAG Regimen In Patients With Myelodysplastic Syndrome
20. Study On The Effect Of Spleen And Marrow Strengthening Method Combined With CAG Regimen For The Quality Of Life Of Elderly Acute Myeloid Leukemia(Spleen-kidney Yang Deficiency Syndrome)
  <<First  <Prev  Next>  Last>>  Jump to